Compound Ranitidine Capsules (复方雷尼替丁胶囊)复方雷尼替丁胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 苏州东瑞制药有限公司Chinese legal name: 苏州东瑞制药有限公司
主要成分Active Ingredients
- 雷尼替丁ranitidine
- 辅料为Excipients recorded as
药物知识说明
雷尼替丁是一种在国家药监局注册认定的药品。该药品含有雷尼替丁-365cd531等成分。
该药品关联的活性成分包括：雷尼替丁ranitidine。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：苏州东瑞制药有限公司Chinese legal name: 苏州东瑞制药有限公司。
您可以探索含有相同成分的其他药品：雷尼替丁-365cd531成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
ranitidine is a medicine registered with the national drug regulatory authority. It contains ranitidine as active ingredient(s).
Active ingredients associated with this product: ranitidineranitidine.
Manufacturers recorded for this product: 苏州东瑞制药有限公司Chinese legal name: 苏州东瑞制药有限公司.
Explore other medicines containing the same ingredient: ranitidine products.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 复方雷尼替丁胶囊Compound Ranitidine Capsules (复方雷尼替丁胶囊)
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 铝塑包装，外套铝箔袋。12粒/板×1/盒。Recorded Chinese description: 铝塑包装，外套铝箔袋。12粒/板×1/盒。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 苏州东瑞制药有限公司Chinese legal name: 苏州东瑞制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20030953
关联实体Relationships
相关问题Questions
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20030953
Manufacturer
Chinese legal name: 苏州东瑞制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20030953
生产企业
苏州东瑞制药有限公司(国产)
适应症
用于慢性胃炎及缓解胃酸过多所致的胃痛、胃灼热感（烧心）、反酸。
用法用量
成人一次一粒，每日二次，餐前口服。疗程不宜超过6周。幽门螺杆菌阳性患者若与抗生素联合应用，抗生素的剂量与疗程遵医嘱。
不良反应
1.常见恶心、便秘、皮疹、乏力、头痛、头晕。
2.服药期间口内可能带有氨味，并可使舌苔及大便呈灰黑色，停药后可自行消失。
3.对肾功能、性腺功能和中枢神经系统的不良反应较西咪替丁轻微。
禁忌
1.严重肾功能不全患者禁用。
2.孕妇禁用。
注意事项
1.连续服用不得超过7天，症状未缓解或消失，请咨询医师或药师。
2.肝、肾功能不全者应慎用。
3.老年患者、哺乳期妇女慎用。
4.不推荐儿童使用本品。
5.对本品过敏者禁用，过敏体质者慎用。
6.本品性状发生改变时禁止使用。
7.请将本品放在儿童不能接触的地方。
8.如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
密封，置阴凉处保存。
规格
铝塑包装，外套铝箔袋。12粒/板×1/盒。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.